Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Guodai Hong, Silun Xie, Zikuan Guo, Diping Zhang, Sihai Ge, Suqin Zhang & Wenbin Gao. (2022) Progression-Free Survival of a Patient with Advanced Hepatocellular Carcinoma Treated with Adoptive Cell Therapy Using Natural Killer Cells: A Case Report. OncoTargets and Therapy 15, pages 255-266.
Read now
Read now
Surojit Karmakar, Pradipta Pal & Girdhari Lal. (2021) Key Activating and Inhibitory Ligands Involved in the Mobilization of Natural Killer Cells for Cancer Immunotherapies. ImmunoTargets and Therapy 10, pages 387-407.
Read now
Read now
Ralph Ja Maas, Janneke S Hoogstad-van Evert, Jolien Mr Van der Meer, Vera Mekers, Somayeh Rezaeifard, Alan J Korman, Paul Kjd de Jonge, Jeannette Cany, Rob Woestenenk, Nicolaas Pm Schaap, Leon F Massuger, Joop H Jansen, Willemijn Hobo & Harry Dolstra. (2020) TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer. OncoImmunology 9:1.
Read now
Read now
Silun Xie, Zhenyi Wu, Lizhi Niu, Jibing Chen, Yunkun Ma & Mingjie Zhang. (2019) Preparation of highly activated natural killer cells for advanced lung cancer therapy. OncoTargets and Therapy 12, pages 5077-5086.
Read now
Read now
Kejian Wang, Yue Han, William C. Cho & Huang Zhu. (2019) The rise of human stem cell-derived natural killer cells for cancer immunotherapy. Expert Opinion on Biological Therapy 19:2, pages 141-148.
Read now
Read now
Wentao Deng, Juhui Qiu, Shaoting Wang, Zhi Yuan, Yuefeng Jia, Hailin Tan, Jiru Lu & Ruqiang Zheng. (2018) Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo. International Journal of Nanomedicine 13, pages 439-453.
Read now
Read now
Jeremiah L. Oyer, Sarah B. Gitto, Deborah A. Altomare & Alicja J. Copik. (2018) PD-L1 blockade enhances anti-tumor efficacy of NK cells. OncoImmunology 7:11.
Read now
Read now
Silun Xie, Zhengyi Wu, Liang Zhou, Yingqing Liang, Xiaohua Wang, Lizhi Niu, Kecheng Xu, Jibing Chen & Mingjie Zhang. (2018) Iodine-125 seed implantation and allogenic natural killer cell immunotherapy for hepatocellular carcinoma after liver transplantation: a case report. OncoTargets and Therapy 11, pages 7345-7352.
Read now
Read now
Wade Chun-Wai Suen, Wayne Yuk-Wai Lee, Kam-Tong Leung, Xiao-Hua Pan & Gang Li. (2018) Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials. Cancer Investigation 36:8, pages 431-457.
Read now
Read now
O. Adotevi, Y. Godet, J. Galaine, Z. Lakkis, I. Idirene, J. M. Certoux, M. Jary, R. Loyon, C. Laheurte, S. Kim, A. Dormoy, F. Pouthier, C. Barisien, F. Fein, P. Tiberghien, X. Pivot, S. Valmary-Degano, C. Ferrand, P. Morel, E. Delabrousse & C. Borg. (2018) In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. OncoImmunology 7:5.
Read now
Read now
Shuzhen Liang, Kecheng Xu, Lizhi Niu, Xiaohua Wang, Yingqing Liang, Mingjie Zhang, Jibing Chen & Mao Lin. (2017) Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer. OncoTargets and Therapy 10, pages 4273-4281.
Read now
Read now
Janneke S. Hoogstad-van Evert, Jeannette Cany, Dirk van den Brand, Manon Oudenampsen, Roland Brock, Ruurd Torensma, Ruud L. Bekkers, Joop H. Jansen, Leon F. Massuger & Harry Dolstra. (2017) Umbilical cord blood CD34+ progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rgnull mice. OncoImmunology 6:8.
Read now
Read now
Zilin Qin, Jibing Chen, Jianying Zeng, Lizhi Niu, Silun Xie, Xiaohua Wang, Yingqing Liang, Zhenyi Wu & Mingjie Zhang. (2017) Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study. Cancer Biology & Therapy 18:5, pages 323-330.
Read now
Read now
Jesus I. Luna, Steven K. Grossenbacher, William J. Murphy & Robert J. Canter. (2017) Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy. Expert Opinion on Biological Therapy 17:3, pages 313-324.
Read now
Read now
Manindra Singh, Tiffany Loftus, Erin Webb & Fabian Benencia. (2016) Minireview: Regulatory T Cells and Ovarian Cancer. Immunological Investigations 45:8, pages 712-720.
Read now
Read now
Markus Granzin, Ana Stojanovic, Matthias Miller, Richard Childs, Volker Huppert & Adelheid Cerwenka. (2016) Highly efficient IL-21 and feeder cell-driven ex vivo expansion of human NK cells with therapeutic activity in a xenograft mouse model of melanoma. OncoImmunology 5:9.
Read now
Read now
Gabriela Maria Wiedemann, Severin Johannes Jacobi, Michael Chaloupka, Angelina Krächan, Svetlana Hamm, Stefan Strobl, Roland Baumgartner, Simon Rothenfusser, Peter Duewell, Stefan Endres & Sebastian Kobold. (2016) A novel TLR7 agonist reverses NK cell anergy and cures RMA-S lymphoma-bearing mice. OncoImmunology 5:7.
Read now
Read now
Myriam N. Bouchlaka, Kai D. Ludwig, Jeremy W. Gordon, Matthew P. Kutz, Bryan P. Bednarz, Sean B. Fain & Christian M. Capitini. (2016) 19F-MRI for monitoring human NK cells in vivo. OncoImmunology 5:5.
Read now
Read now
U. Koehl, C. Kalberer, J. Spanholtz, D. A. Lee, J. S. Miller, S. Cooley, M. Lowdell, L. Uharek, H. Klingemann, A. Curti, W. Leung & E. Alici. (2016) Advances in clinical NK cell studies: Donor selection, manufacturing and quality control. OncoImmunology 5:4.
Read now
Read now
Sandeep Nayar, Prokar Dasgupta & Christine Galustian. (2015) Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review. OncoImmunology 4:4.
Read now
Read now
Kathrin Meinhardt, Irena Kroeger, Ruth Bauer, Franziska Ganss, Ilja Ovsiy, Johanna Rothamer, Maike Büttner, Imke Atreya, Maximilian Waldner, Max Bittrich, Christian HK Lehmann, Michael A Rieger, Andreas Beilhack, Robert Zeiser, Matthias Edinger, Diana Dudziak, Andreas Mackensen, Michael Rehli & Evelyn Ullrich. (2015) Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects. OncoImmunology 4:1.
Read now
Read now
Giuseppe Bronte, Giuseppe Cicero, Giovanni Sortino, Gianfranco Pernice, Maria Teresa Catarella, Paolo D'Alia, Stefania Cusenza, Silvia Lo Dico, Enrico Bronte, Delia Sprini, Massimo Midiri, Alberto Firenze, Eugenio Fiorentino, Viviana Bazan, Christian Rolfo & Antonio Russo. (2014) Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?. Expert Opinion on Biological Therapy 14:1, pages 103-114.
Read now
Read now
Gina M. Mantia-Smaldone, Bradley Corr & Christina S. Chu. (2012) Immunotherapy in ovarian cancer. Human Vaccines & Immunotherapeutics 8:9, pages 1179-1191.
Read now
Read now
Christiane L. Mallett, Catherine Mcfadden, Yuhua Chen & Paula J. Foster. (2012) Migration of iron-labeled KHYG-1 natural killer cells to subcutaneous tumors in nude mice, as detected by magnetic resonance imaging. Cytotherapy 14:6, pages 743-751.
Read now
Read now
Susan Blaydes Ingersoll, Gregory P. Stoltzfus, Mohammed H. Merchant, Sarfraz Ahmad, Collin R. Edwards, Ahad Ahmed, Jeremiah L. Oyer, Neil J. Finkler, Robert W. Holloway & John R. Edwards. (2012) Comparison of the cytotoxic response against ovarian cancer by immune effector cells isolated and expanded from normal donors and ovarian cancer patients. Cytotherapy 14:6, pages 716-723.
Read now
Read now
Lorenzo Galluzzi, Erika Vacchelli, Alexander Eggermont, Wolf Herve´ Fridman, Jerome Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel & Guido Kroemer. (2012) Trial Watch. OncoImmunology 1:3, pages 306-315.
Read now
Read now
Suzanne R. Thibodeaux & Tyler J. Curiel. (2011) Immune Therapy for Ovarian Cancer: Promise and Pitfalls. International Reviews of Immunology 30:2-3, pages 102-119.
Read now
Read now